You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. N/A

    SBC: BIOCACHE PHARMACEUTICALS, INC.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  2. Novel fetal heart monitor technology

    SBC: Bioconnexions, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Significant progress has been made in the science of electrocardiography since 1938. Heart rate and biophysical profiles are routinely derived from multi-lead electrocardiograms (ECGs) in animals and humans after birth. In contrast, only limited heart monitoring technologies exist for the fetus. Moreover, available technology fails to satisfy many existing need ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  3. Ultra-micro oxygen sensor development

    SBC: Biocurrents Research, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall aim of this STTR proposal is to take an innovative, successful; laboratory based technology and transfer it to the commercial sector. Specifically, we wish to establish the capabilities within the Company to manufacture reliable, robust and inexpensive ultra-micro oxygen sensors suitable for electrochemical applications related to cellular metabolis ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  4. NASALLY-DELIVERED MUCOSAL SUBUNIT VACCINE FOR PLAGUE

    SBC: BIODEFENSE TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): We have developed a plant-based adjuvant/carrier:antigen fusion technology that offers significant advantages over conventional injectable vaccination regimes including: safety, mucosal efficacy, ease of delivery, rapid scalability, unlimited supply potential, and cost-savings. This technology has significant potential in contributing to biodefense strategies ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. Bioscience Research Integration Software Platform

    SBC: BIOFORTIS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The need to investigate and understand all elements of biological information pertinent to disease is more clearly evident now than ever before. However, the avalanche of non-integrated data produced by today's technologies prevents scientists from effectively reducing these data to meaningful discoveries. As a result, the vast bulk of data collected through ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Bioscience Research Integration Software Platform

    SBC: BIOFORTIS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The need to investigate and understand all elements of biological information pertinent to disease is more clearly evident now than ever before. However, the avalanche of non-integrated data produced by today's technologies prevents scientists from effectively reducing these data to meaningful discoveries. As a result, the vast bulk of data collected through ...

    STTR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  7. N/A

    SBC: Biokeys, Inc.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  8. GLASS-FIBER GEL MATRIX FOR PEPTIDE SYNTHESIS

    SBC: BIOLINK PARTNERS            Topic: N/A

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  9. Phenotyping All Genes of S. cerevisiae

    SBC: BIOLOG, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this project is to further develop, miniaturize, and extend the new Phenotype MicroArray (PM) platform technology (1-3) and then utilize this improved technology to genomically analyze biological pathways and gene function in the model eucaryotic microorganism Saccharomyces cerevisiae. The steps will be 1) development of miniaturized, more eff ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Phenotype MicroArray Analysis of Fastidious Pathogens

    SBC: BIOLOG, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The principal goal of this project is to adapt the "Phenotype MicroArray[TM]" ("PM") technology of Biolog, Inc (Hayward, CA) for fastidious and microaerophilic bacterial species, with special emphasis on those important in human disease. PM technology allows efficient, sensitive characterization of thousands of physiologic and phenotypic properties of microbia ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government